Camden National appoints Raina Maxwell to Board of Directors effective Feb 25, 2025

CAMDEN NATIONAL CORP

Board expanded to 12 members; Raina Maxwell appointed as director effective Feb 25, 2025.
Ms. Maxwell brings over 13 years of customer experience at L.L.Bean and financial roles at S&P/PricewaterhouseCoopers.
She will receive pro-rated cash retainers of $41,250 (board) and $2,292 (Credit Committee) plus $11,667 equity grant.
Appointment is part of strategic board enhancement; committee assignment: Credit Committee.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Raina Maxwell

Director

CAC · CAMDEN NATIONAL CORP

Effective: 2025-02-25
Filed: February 26, 2025, 6:59 PM ET

On February 25, 2025, the Board of Directors of Camden National Corporation (the “Company”) increased the size of the Company’s Board of Directors (the “Board”) to 12 members and elected Ms. Raina Maxwell to fill the vacancy created upon the increase in the size of the Board, in each case, effective February 25, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Raina Maxwell was elected as Director at CAMDEN NATIONAL CORP.

Action: elected
Role: Director

Exact text from the filing

On February 25, 2025, the Board of Directors of Camden National Corporation (the “Company”) increased the size of the Company’s Board of Directors (the “Board”) to 12 members and elected Ms. Raina Maxwell to fill the vacancy created upon the increase in the size of the Board, in each case, effective February 25, 2025.

View on SEC.gov

CAMDEN NATIONAL CORP filing history →

Source: SEC EDGAR

accession 0000750686-25-000036

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.